drugset / Trial / NCT01262586
Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.
RandomizedCrossoverOpen-labelTreatment
Summary
This study will use Continuous Glucose Monitoring to assess differences in glycemic profiles between vildagliptin and glimepiride.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glimepiride | Small molecule | 2 mg | — |
| Subject | Vildagliptin | Other / unclassified | 50 mg | — |